• 文献检索
  • 文档翻译
  • 深度研究
  • 学术资讯
  • Suppr Zotero 插件Zotero 插件
  • 邀请有礼
  • 套餐&价格
  • 历史记录
应用&插件
Suppr Zotero 插件Zotero 插件浏览器插件Mac 客户端Windows 客户端微信小程序
定价
高级版会员购买积分包购买API积分包
服务
文献检索文档翻译深度研究API 文档MCP 服务
关于我们
关于 Suppr公司介绍联系我们用户协议隐私条款
关注我们

Suppr 超能文献

核心技术专利：CN118964589B侵权必究
粤ICP备2023148730 号-1Suppr @ 2026

文献检索

告别复杂PubMed语法，用中文像聊天一样搜索，搜遍4000万医学文献。AI智能推荐，让科研检索更轻松。

立即免费搜索

文件翻译

保留排版，准确专业，支持PDF/Word/PPT等文件格式，支持 12+语言互译。

免费翻译文档

深度研究

AI帮你快速写综述，25分钟生成高质量综述，智能提取关键信息，辅助科研写作。

立即免费体验

Early detection of gastric cancer in China: progress and opportunities.

作者信息

Xu Hengmin, Li Wenqing

机构信息

Key Laboratory of Carcinogenesis and Translational Research (Ministry of Education/Beijing), Department of Cancer Epidemiology, Peking University Cancer Hospital and Institute, Beijing 100142, China.

出版信息

Cancer Biol Med. 2022 Dec 12;19(12):1622-8. doi: 10.20892/j.issn.2095-3941.2022.0655.

DOI:10.20892/j.issn.2095-3941.2022.0655
PMID:36514907
原文链接:https://pmc.ncbi.nlm.nih.gov/articles/PMC9755958/
Abstract
摘要
https://cdn.ncbi.nlm.nih.gov/pmc/blobs/048c/9755958/02942c22aefe/cbm-19-1622-g001.jpg
https://cdn.ncbi.nlm.nih.gov/pmc/blobs/048c/9755958/02942c22aefe/cbm-19-1622-g001.jpg
https://cdn.ncbi.nlm.nih.gov/pmc/blobs/048c/9755958/02942c22aefe/cbm-19-1622-g001.jpg

相似文献

1
Early detection of gastric cancer in China: progress and opportunities.中国胃癌的早期检测：进展与机遇。
Cancer Biol Med. 2022 Dec 12;19(12):1622-8. doi: 10.20892/j.issn.2095-3941.2022.0655.
2
[Progress on screening for gastric cancer].[胃癌筛查的进展]
Zhonghua Zhong Liu Za Zhi. 2020 Jul 23;42(7):603-608. doi: 10.3760/cma.j.cn112152-20191125-00759.
3
Effectiveness of endoscopic gastric cancer screening in a rural area of Linzhou, China: results from a case-control study.中国林州农村地区内镜胃癌筛查的有效性：一项病例对照研究的结果
Cancer Med. 2016 Sep;5(9):2615-22. doi: 10.1002/cam4.812. Epub 2016 Jul 1.
4
Esophageal/gastric cancer screening in high-risk populations in Henan Province, China.中国河南省高危人群的食管癌/胃癌筛查
Asian Pac J Cancer Prev. 2014;15(3):1419-22. doi: 10.7314/apjcp.2014.15.3.1419.
5
[Current status and future prospects of gastric cancer screening in Japan].[日本胃癌筛查的现状与未来展望]
Nihon Shokakibyo Gakkai Zasshi. 2020;117(6):454-462. doi: 10.11405/nisshoshi.117.454.
6
Endoscopic diagnosis of gastric cancer: an analysis of 872 cases in China.胃癌的内镜诊断：中国872例病例分析
Gastrointest Endosc. 1985 Jun;31(3):191-5. doi: 10.1016/s0016-5107(85)72042-1.
7
The prescreening tool for gastric cancer in China.中国的胃癌预筛查工具。
Gut. 2020 Sep;69(9):1. doi: 10.1136/gutjnl-2019-319591. Epub 2019 Sep 3.
8
Gastric carcinoma: early detection and prognosis.胃癌：早期检测与预后
West Indian Med J. 2008 Jan;57(1):1.
9
Epidemiology of precancerous gastric lesions.胃癌前病变的流行病学
J Gastroenterol Hepatol. 1993 Jul-Aug;8(4):375-82. doi: 10.1111/j.1440-1746.1993.tb01531.x.
10
Linked Color Imaging Can Improve Detection Rate of Early Gastric Cancer in a High-Risk Population: A Multi-Center Randomized Controlled Clinical Trial.链接显色内镜成像技术可提高高危人群早期胃癌检出率：一项多中心随机对照临床试验。
Dig Dis Sci. 2021 Apr;66(4):1212-1219. doi: 10.1007/s10620-020-06289-0. Epub 2020 May 4.

引用本文的文献

1
Global lifetime estimates of expected and preventable gastric cancers across 185 countries.185个国家胃癌预期发病数和可预防发病数的全球终生估计。
Nat Med. 2025 Jul 7. doi: 10.1038/s41591-025-03793-6.
2
The potential value of serum pepsinogen and gastrin-17 for the diagnosis of chronic atrophic gastritis at different stages of severity: a clinical diagnostic study.血清胃蛋白酶原和胃泌素-17在不同严重程度慢性萎缩性胃炎诊断中的潜在价值：一项临床诊断研究
BMC Gastroenterol. 2025 Jun 4;25(1):428. doi: 10.1186/s12876-025-03996-8.
3
Temporospatial variation in environmental risk factors and related gastric cancer incidence: a registry-based study in an area with the largest gastric cancer burden in China.

本文引用的文献

1
Cancer incidence and mortality in China, 2016.2016年中国癌症的发病率和死亡率
J Natl Cancer Cent. 2022 Feb 27;2(1):1-9. doi: 10.1016/j.jncc.2022.02.002. eCollection 2022 Mar.
2
Current cancer burden in China: epidemiology, etiology, and prevention.当前中国的癌症负担：流行病学、病因学和预防。
Cancer Biol Med. 2022 Aug 30;19(8):1121-38. doi: 10.20892/j.issn.2095-3941.2022.0231.
3
Nationwide gastric cancer prevention in China, 2021-2035: a decision analysis on effect, affordability and cost-effectiveness optimisation.
环境危险因素的时空变化与相关胃癌发病率：一项基于登记系统的研究，在中国胃癌负担最重的地区开展
J Glob Health. 2025 Jun 2;15:04083. doi: 10.7189/jogh.15.04083.
4
Pathologic complete response after Sintilimab combined with FOLFOX therapy in MSI-H type patients with locally advanced GC: a case report.信迪利单抗联合FOLFOX方案治疗微卫星高度不稳定型局部进展期胃癌患者的病理完全缓解：1例病例报告
Front Oncol. 2025 May 8;15:1560450. doi: 10.3389/fonc.2025.1560450. eCollection 2025.
5
Optimal response population after neoadjuvant therapy for patients with locally advanced gastric cancer: A multicenter study.局部晚期胃癌患者新辅助治疗后的最佳反应人群：一项多中心研究。
Chin J Cancer Res. 2025 Apr 30;37(2):174-186. doi: 10.21147/j.issn.1000-9604.2025.02.05.
6
Atezolizumab and Trastuzumab Plus Chemotherapy for ERBB2-Positive Locally Advanced Resectable Gastric Cancer: A Randomized Clinical Trial.阿替利珠单抗与曲妥珠单抗联合化疗治疗ERBB2阳性局部晚期可切除胃癌：一项随机临床试验
JAMA Oncol. 2025 Apr 17. doi: 10.1001/jamaoncol.2025.0522.
7
Trends in Stomach Cancer Burden in China: A Joinpoint and APC Analysis Based on GBD 2021.中国胃癌负担趋势：基于全球疾病负担研究（GBD）2021的连接点和年龄-时期-队列分析
J Gastroenterol Hepatol. 2025 Jun;40(6):1500-1514. doi: 10.1111/jgh.16956. Epub 2025 Apr 1.
8
Machine learning models for prediction of lymph node metastasis in patients with gastric cancer: a Chinese single-centre study with external validation in an Asian American population.用于预测胃癌患者淋巴结转移的机器学习模型：一项在中国单中心开展并在亚裔美国人群中进行外部验证的研究
BMJ Open. 2025 Mar 25;15(3):e098476. doi: 10.1136/bmjopen-2024-098476.
9
Coagulation indices and fibrinogen degradation products as predictive biomarkers for tumor-node-metastasis staging and metastasis in gastric cancer.凝血指标和纤维蛋白原降解产物作为胃癌肿瘤-淋巴结-转移分期及转移的预测生物标志物。
World J Gastrointest Oncol. 2025 Jan 15;17(1):98725. doi: 10.4251/wjgo.v17.i1.98725.
10
Identification and validation of serum MUC17 as a non-invasive early warning biomarker for screening of gastric intraepithelial neoplasia.血清MUC17作为胃上皮内瘤变筛查的非侵入性早期预警生物标志物的鉴定与验证
Transl Oncol. 2025 Jan;51:102207. doi: 10.1016/j.tranon.2024.102207. Epub 2024 Nov 23.
中国 2021-2035 年全国胃癌防治：基于效果、负担和成本效益优化的决策分析
Gut. 2022 Dec;71(12):2391-2400. doi: 10.1136/gutjnl-2021-325948. Epub 2022 Jul 28.
4
[China guideline for the screening, early detection and early treatment of gastric cancer (2022, Beijing)].《中国胃癌筛查与早诊早治指南（2022年，北京）》
Zhonghua Zhong Liu Za Zhi. 2022 Jul 23;44(7):634-666. doi: 10.3760/cma.j.cn112152-20220617-00430.
5
Frequent low dose alcohol intake increases gastric cancer risk: the Health Examinees-Gem (HEXA-G) study.频繁小剂量饮酒会增加胃癌风险：健康检查者-基因（HEXA-G）研究。
Cancer Biol Med. 2022 Apr 28;19(8):1224-34. doi: 10.20892/j.issn.2095-3941.2021.0642.
6
The future of early cancer detection.早期癌症检测的未来。
Nat Med. 2022 Apr;28(4):666-677. doi: 10.1038/s41591-022-01746-x. Epub 2022 Apr 19.
7
Fecal Signatures of Streptococcus anginosus and Streptococcus constellatus for Noninvasive Screening and Early Warning of Gastric Cancer.咽峡炎链球菌和星座链球菌的粪便特征用于胃癌的无创筛查和早期预警
Gastroenterology. 2022 Jun;162(7):1933-1947.e18. doi: 10.1053/j.gastro.2022.02.015. Epub 2022 Feb 12.
8
Beneficial effects of endoscopic screening on gastric cancer and optimal screening interval: a population-based study.内镜筛查对胃癌的有益影响及最佳筛查间隔：一项基于人群的研究。
Endoscopy. 2022 Sep;54(9):848-858. doi: 10.1055/a-1728-5673. Epub 2021 Dec 28.
9
Proteomic profiling identifies signatures associated with progression of precancerous gastric lesions and risk of early gastric cancer.蛋白质组学分析鉴定出与癌前胃病变进展和早期胃癌风险相关的特征。
EBioMedicine. 2021 Dec;74:103714. doi: 10.1016/j.ebiom.2021.103714. Epub 2021 Nov 22.
10
Estimated Cost-effectiveness of Endoscopic Screening for Upper Gastrointestinal Tract Cancer in High-Risk Areas in China.中国高危地区上消化道癌内镜筛查的成本效益估计
JAMA Netw Open. 2021 Aug 2;4(8):e2121403. doi: 10.1001/jamanetworkopen.2021.21403.